The National Institute of Allergy and Infectious Diseases (NIAID) awarded National Jewish Health a $612,328 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to investigate the role of the transcription factor MITF in regulating mast cell lineage commitment and function. The research aims to enhance understanding of mast cell-specific gene expression and suppression of basophil-specific genes, as well as evaluate the functional impact of deleting the MITF gene in mast cells on antibody-mediated and drug-induced anaphylaxis. This 5-year project, commencing on December 2, 2024, seeks to advance the scientific understanding of mast cell biology and provide insights that could lead to new therapeutic approaches for mast cell-mediated diseases.
Generated 2/25/25, 5:05 AM